Vascular restenosis - striving for therapy (Q35925488)

11 August 2017

1 reference

title

Vascular restenosis - striving for therapy (English)

1 reference

11 August 2017

Thomas M Schiele

1

1 reference

11 August 2017

Florian Krötz

series ordinal

2

1 reference

11 August 2017

Volker Klauss

series ordinal

3

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 November 2004

1 reference

Expert Opinion on Pharmacotherapy

11 August 2017

1 reference

11 August 2017

5

1 reference

11 August 2017

11

1 reference

11 August 2017

2221-2232

1 reference

Advances in coronary angioplasty

11 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2221

Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2221

Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2221

Clinical risk factors for ischemic complications after percutaneous coronary interventions: results from the EPIC trial. The EPIC Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2221

Periprocedural quantitative coronary angiography after Palmaz-Schatz stent implantation predicts the restenosis rate at six months: results of a meta-analysis of the BElgian NEtherlands Stent study (BENESTENT) I, BENESTENT II Pilot, BENESTENT II and

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2221

Angiographic and intravascular ultrasound predictors of in-stent restenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2221

Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: the multicenter U.S. Palmaz-Schatz stent experience. The Palmaz-Schatz Stent Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2221

Pilot trial of oral rapamycin for recalcitrant restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2221

Treatment of diffuse in-stent restenosis with rotational atherectomy followed by radiation therapy with a rhenium-188-mercaptoacetyltriglycine-filled balloon

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2221

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2221

Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2221

Sustained benefit of stenting chronic coronary occlusion: long-term clinical follow-up of the Stenting in Chronic Coronary Occlusion (SICCO) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2221

Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2221

Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2221

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2221

Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2221

Can we afford to eliminate restenosis? Can we afford not to?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2221

A multicentre European registry of intraluminal coronary beta brachytherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2221

Clinical and angiographic acute and follow up results of intracoronary beta brachytherapy in saphenous vein bypass grafts: a subgroup analysis of the multicentre European registry of intraluminal coronary beta brachytherapy (RENO)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2221

Role of basic fibroblast growth factor in vascular lesion formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.11.2221

10.1517/14656566.5.11.2221

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference